0,914  0,002  Cholesterol antagonist
0,899  0,005  Cyclophilin D inhibitor
0,899  0,005  Antidiabetic
0,895  0,005  Antiinflammatory
0,874  0,004  Antihypercholesterolemic
0,869  0,004  Caspase 9 stimulant
0,853  0,003  Angiogenesis stimulant
0,847  0,003  Antithrombotic
0,824  0,002  Mediator release inhibitor
0,819  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,810  0,004  Cardioprotectant
0,803  0,005  Radioprotector
0,799  0,003  Antihypoxic
0,796  0,003  Antimutagenic
0,788  0,018  Apoptosis agonist
0,771  0,003  Interleukin agonist
0,771  0,005  Antioxidant
0,768  0,002  Amylase inhibitor
0,769  0,011  Teratogen
0,763  0,007  Chemoprotective
0,760  0,004  Vasodilator, peripheral
0,756  0,010  TNF expression inhibitor
0,755  0,011  Embryotoxic
0,749  0,005  Immunomodulator
0,747  0,008  Respiratory analeptic
0,743  0,004  Hypoglycemic
0,742  0,007  Mutagenic
0,728  0,004  Vasodilator, coronary
0,728  0,005  NOS3 expression inhibitor
0,727  0,005  Proliferative diseases treatment
0,716  0,005  Antiparasitic
0,714  0,006  NOS2 expression inhibitor
0,714  0,006  5 Hydroxytryptamine release stimulant
0,711  0,005  Nitric oxide antagonist
0,707  0,005  Antidiabetic (type 2)
0,720  0,018  Transcription factor NF kappa B inhibitor
0,705  0,005  Hepatic disorders treatment
0,700  0,010  Chemopreventive
0,696  0,008  Immunostimulant
0,690  0,005  Apoptosis antagonist
0,693  0,008  Analeptic
0,692  0,012  Carcinogenic
0,676  0,006  Lipoprotein disorders treatment
0,670  0,003  Aldose reductase substrate
0,677  0,011  Antibacterial
0,662  0,005  Antipruritic, allergic
0,650  0,003  Interleukin 2 agonist
0,650  0,005  Antihelmintic
0,648  0,005  Antihypertriglyceridemic
0,646  0,003  VCAM1 expression inhibitor
0,643  0,004  Monophenol monooxygenase inhibitor
0,641  0,005  Genotoxic
0,641  0,005  Vascular (periferal) disease treatment
0,640  0,005  Tumour necrosis factor alpha release inhibitor
0,654  0,023  CYP3A4 substrate
0,634  0,004  Septic shock treatment
0,623  0,011  UGT1A9 substrate
0,617  0,011  Immunosuppressant
0,604  0,004  Anesthetic general
0,606  0,011  Cytotoxic
0,604  0,010  Caspase 3 stimulant
0,594  0,002  Antineoplastic, alkylator
0,598  0,007  DNA synthesis inhibitor
0,595  0,009  Free radical scavenger
0,601  0,015  Sensitization
0,588  0,005  Hepatoprotectant
0,580  0,004  ICAM1 expression inhibitor
0,576  0,004  UGT2B4 substrate
0,581  0,013  Cytostatic
0,570  0,004  Platelet adhesion inhibitor
0,573  0,008  UDP-glucuronosyltransferase substrate
0,574  0,016  Stroke treatment
0,562  0,008  Vasodilator
0,555  0,001  Alpha-mannosidase inhibitor
0,565  0,012  Antifungal
0,561  0,008  Hypolipemic
0,550  0,003  NADH dehydrogenase inhibitor
0,550  0,003  Protein kinase stimulant
0,555  0,009  Platelet antagonist
0,549  0,015  AR expression inhibitor
0,564  0,031  Antineoplastic (solid tumors)
0,533  0,002  Selectin antagonist
0,537  0,012  Eye irritation, high
0,529  0,005  Interferon gamma antagonist
0,525  0,001  Mannosidase inhibitor
0,526  0,002  Triose-phosphate isomerase inhibitor
0,526  0,002  Antihelmintic (Nematodes)
0,523  0,004  Alkylator
0,510  0,002  UDP-glucose 4-epimerase inhibitor
0,517  0,010  Antidiabetic symptomatic
0,509  0,005  NOS3 expression enhancer
0,507  0,004  Carcinogenic, group 1
0,501  0,003  Antihemorrhagic
0,513  0,018  Antineoplastic (brain cancer)
0,506  0,013  DNA damaging
0,492  0,002  Phosphofructokinase-1 inhibitor
0,488  0,007  Melanin inhibitor
0,490  0,010  UGT1A1 substrate
0,482  0,005  Muscular dystrophy treatment
0,504  0,031  Atherosclerosis treatment
0,480  0,008  Antiviral (Herpes)
0,479  0,008  Skin whitener
0,474  0,004  Antipruritic, non-allergic
0,469  0,005  Acaricide
0,479  0,015  Antineoplastic (lymphoma)
0,465  0,004  Antifungal enhancer
0,464  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,499  0,040  Antileukemic
0,465  0,013  Myocardial infarction treatment
0,493  0,042  GST A substrate
0,463  0,013  Radiosensitizer
0,470  0,021  Antineoplastic (multiple myeloma)
0,466  0,021  Antiprotozoal (Leishmania)
0,451  0,007  Lipid peroxidase inhibitor
0,477  0,038  Histamine release inhibitor
0,442  0,004  Retinoprotector
0,449  0,016  Antineoplastic (endocrine cancer)
0,442  0,009  Non-steroidal antiinflammatory agent
0,456  0,026  Antimycobacterial
0,444  0,014  RNA-directed DNA polymerase inhibitor
0,450  0,028  Antineoplastic (pancreatic cancer)
0,421  0,009  DNA methylase inhibitor
0,410  0,003  Vanilloid 1 agonist
0,439  0,036  Antineoplastic (ovarian cancer)
0,397  0,004  AMP-activated protein kinase stimulant
0,416  0,024  Antiglaucomic
0,423  0,031  Metabolic disease treatment
0,407  0,018  Antiulcerative
0,399  0,012  Antihypotensive
0,393  0,006  DNA polymerase I inhibitor
0,389  0,007  Antidiabetic (type 1)
0,416  0,037  Spasmolytic
0,385  0,006  Glutathione S-transferase substrate
0,380  0,002  Interferon agonist
0,390  0,013  Diabetic retinopathy treatment
0,382  0,005  Neuropathy treatment
0,430  0,053  CYP2C9 substrate
0,395  0,019  Wound healing agent
0,380  0,004  ATPase inhibitor
0,379  0,004  Antifungal (Cryptococcus)
0,386  0,012  Antiviral (Influenza)
0,375  0,005  Hexokinase inhibitor
0,371  0,005  Interleukin 4 antagonist
0,404  0,038  Antiischemic
0,382  0,018  Skin irritative effect
0,388  0,024  Antineoplastic (osteosarcoma)
0,366  0,004  Antispirochetal
0,431  0,071  Antineoplastic (breast cancer)
0,366  0,007  Cell wall synthesis inhibitor
0,367  0,010  Peptidyltransferase inhibitor
0,364  0,008  Neurotrophic factor enhancer
0,353  0,003  Transcription factor NF kappa B stimulant
0,446  0,097  Alpha-glucosidase inhibitor
0,351  0,004  Photosensitizer
0,375  0,028  Antineoplastic (liver cancer)
0,354  0,007  Aldehyde dehydrogenase inhibitor
0,355  0,008  Insulin secretagoues
0,346  0,001  Sodium/glucose cotransporter inhibitor
0,376  0,032  Antipyretic
0,406  0,063  Antineoplastic (lung cancer)
0,424  0,082  Antiarthritic
0,340  0,002  Glucosylceramidase inhibitor
0,339  0,008  Topoisomerase I inhibitor
0,334  0,004  Vanilloid agonist
0,374  0,045  CYP2C19 substrate
0,338  0,011  Antidote
0,350  0,025  Sedative
0,328  0,002  Gaucher disease treatment
0,328  0,008  Cell adhesion inhibitor
0,330  0,016  Phospholipase C inhibitor
0,321  0,007  Expectorant
0,315  0,003  Phosphodiesterase 6D inhibitor
0,384  0,072  Antiobesity
0,313  0,002  Interferon inducer
0,315  0,005  Alcohol dehydrogenase substrate
0,362  0,053  Antipsoriatic
0,344  0,037  Antineoplastic (renal cancer)
0,374  0,071  Ulceration
0,328  0,030  Antineoplastic (sarcoma)
0,299  0,001  Glucose-6-phosphate isomerase inhibitor
0,315  0,018  Hair growth stimulant
0,314  0,020  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,307  0,015  Hemostatic
0,301  0,009  Antineoplastic antibiotic
0,292  0,004  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,302  0,016  Diabetic nephropathy treatment
0,319  0,035  Cyclic AMP phosphodiesterase inhibitor
0,290  0,007  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,287  0,004  Carcinogenic, group 2A
0,376  0,094  5 Hydroxytryptamine release inhibitor
0,304  0,025  UGT2B7 substrate
0,301  0,026  DNA methyltransferase I inhibitor
0,282  0,008  Adenylate kinase inhibitor
0,327  0,054  Antituberculosic
0,281  0,009  Neurotrophic factor
0,273  0,004  Sphingomyelinase inhibitor
0,271  0,004  Toll-Like receptor 4 antagonist
0,309  0,043  Amyloid beta aggregation inhibitor
0,267  0,003  Antiviral (Dengue virus)
0,311  0,055  Huntington's disease treatment
0,326  0,074  Prostate cancer treatment
0,274  0,023  Insulin sensitizer
0,264  0,016  Antihyperlipoproteinemic
0,364  0,117  Alzheimer's disease treatment
0,296  0,050  GST M1-1 substrate
0,319  0,076  FMO1 substrate
0,258  0,019  Antidiarrheal
0,246  0,007  Aldehyde dehydrogenase substrate
0,315  0,076  Antineoplastic (colorectal cancer)
0,242  0,006  Antiviral (Influenza B)
0,277  0,041  Antiviral (HIV)
0,251  0,017  Antiprotozoal (Coccidial)
0,238  0,006  DNA repair enzyme inhibitor
0,245  0,013  Xanthine oxidase inhibitor
0,249  0,017  Psychosexual dysfunction treatment
0,314  0,084  Antiallergic
0,240  0,010  Choleretic
0,239  0,010  Cyclooxygenase 3 inhibitor
0,247  0,019  Antiviral (Hepatitis B)
0,242  0,014  Mannose-6-phosphate isomerase inhibitor
0,256  0,030  Antiviral (Hepatitis)
0,227  0,001  Sodium/glucose cotransporter 2 inhibitor
0,241  0,016  UGT2B10 substrate
0,228  0,005  Adenylate cyclase stimulant
0,241  0,019  Uterine stimulant
0,234  0,013  Microtubule formation inhibitor
0,253  0,033  Sepsis treatment
0,274  0,055  Antineoplastic (glioblastoma multiforme)
0,229  0,010  Antibiotic
0,243  0,024  Interleukin 6 antagonist
0,244  0,026  Antiviral (Influenza A)
0,272  0,056  Gastrin inhibitor
0,217  0,006  Toll-Like receptor 2 agonist
0,220  0,010  Mucolytic
0,245  0,035  Thrombolytic
0,296  0,088  Bone diseases treatment
0,239  0,033  Antineoplastic (gastric cancer)
0,211  0,004  Glutamate release inhibitor
0,283  0,077  Antineoplastic (melanoma)
0,223  0,018  Antirickettsial
0,258  0,058  UGT1A6 substrate
0,226  0,026  Antiviral (Ebola)
0,266  0,069  Antineoplastic (glioma)
0,201  0,004  Ca2+-transporting ATPase inhibitor
0,215  0,019  Antibacterial (Helicobacter pylori)
0,204  0,009  Antimetabolite
0,237  0,043  Nitric-oxide synthase stimulant
0,309  0,118  CYP2C19 inhibitor
0,261  0,070  Antineoplastic (cervical cancer)
0,221  0,033  Phospholipase A2 inhibitor
0,202  0,015  Growth stimulant
0,252  0,066  Antineoplastic (lymphocytic leukemia)
0,238  0,052  Abortion inducer
0,220  0,034  Cystic fibrosis treatment
0,271  0,086  Antineoplastic (colon cancer)
0,254  0,069  Antiamyloidogenic
0,204  0,019  Antiviral (Poxvirus)
0,186  0,004  Antibiotic Glycopeptide-like
0,186  0,005  Phosphodiesterase VI inhibitor
0,194  0,014  Dementia treatment
0,229  0,049  P-glycoprotein inhibitor
0,200  0,021  CF transmembrane conductance regulator agonist
0,190  0,014  Vascular dementia treatment
0,197  0,022  Carcinogenic, group 2B
0,181  0,006  Antiviral (Herpesvirus 3, Human)
0,192  0,018  Hearing loss treatment
0,187  0,013  Chronic obstructive bronchitis treatment
0,183  0,010  Thioredoxin inhibitor
0,249  0,078  Antineoplastic (non-small cell lung cancer)
0,186  0,017  Antiviral (CMV)
0,253  0,089  Antiosteoporotic
0,168  0,005  Glycine receptor antagonist
0,165  0,003  Heparanase inhibitor
0,204  0,043  Restenosis treatment
0,185  0,025  Antineoplastic antimetabolite
0,290  0,131  Antiprotozoal
0,200  0,042  Antineoplastic (squamous cell carcinoma)
0,159  0,004  Antimycoplasmal
0,194  0,039  Arachidonic acid antagonist
0,197  0,043  Antiviral (Hepatitis C)
0,174  0,021  UGT2B1 substrate
0,183  0,030  Antitussive
0,172  0,021  Sulfotransferase substrate
0,155  0,005  Na+ K+ transporting ATPase inhibitor
0,155  0,006  ATPase (Vacuolar H+) inhibitor
0,147  0,002  Sodium/glucose cotransporter 1 inhibitor
0,165  0,020  Topoisomerase II alpha inhibitor
0,189  0,045  Antiacne
0,155  0,013  UGT2B11 substrate
0,156  0,014  Cell adhesion molecule inhibitor
0,159  0,018  Actinic keratosis treatment
0,150  0,009  Acyl-CoA dehydrogenase inhibitor
0,167  0,028  Antischistosomal
0,175  0,040  Topoisomerase II inhibitor
0,142  0,007  Protein 50S ribosomal subunit inhibitor
0,133  0,003  Cytokine production stimulant
0,169  0,040  Toll-Like receptor 2 antagonist
0,126  0,002  Ceramide glucosyltransferase inhibitor
0,148  0,024  Myasthenia Gravis treatment
0,131  0,009  Phosphorylase inhibitor
0,135  0,013  Carbamoyl phosphate synthetase inhibitor
0,134  0,013  Thioredoxin reductase inhibitor
0,158  0,037  Gout treatment
0,171  0,051  Antinephritic
0,145  0,027  Beta glucuronidase inhibitor
0,230  0,118  CYP2D6 substrate
0,136  0,025  Carbonic anhydrase XIII inhibitor
0,153  0,043  Adenylate cyclase inhibitor
0,129  0,019  Restless leg syndrome treatment
0,136  0,026  Anabolic
0,109  0,003  Antibiotic Aminoglycoside-like
0,225  0,122  CYP1A2 substrate
0,173  0,072  Liver fibrosis treatment
0,247  0,146  Antineoplastic (small cell lung cancer)
0,117  0,017  GABA aminotransferase inhibitor
0,238  0,141  Sodium/bile acid cotransporter inhibitor
0,133  0,036  Carbonic anhydrase III inhibitor
0,150  0,054  Antieczematic
0,105  0,010  Carbonic anhydrase XIV inhibitor
0,096  0,003  Uridine phosphorylase inhibitor
0,097  0,003  Cholesterol absorption inhibitor
0,122  0,029  Carbonic anhydrase VI inhibitor
0,130  0,038  Neutropenia treatment
0,097  0,006  Adenosine deaminase inhibitor
0,199  0,109  Acute neurologic disorders treatment
0,102  0,014  Antitreponemal
0,097  0,010  Nitric oxide donor
0,115  0,028  Antifungal (Candida)
0,093  0,006  Squalene epoxidase inhibitor
0,127  0,042  GST P1-1 substrate
0,152  0,068  UGT2B15 substrate
0,100  0,016  Neuraminidase (influenza) inhibitor
0,090  0,006  Adenine nucleotide translocase inhibitor
0,116  0,033  Interleukin 12 antagonist
0,176  0,093  Growth factor agonist
0,086  0,004  Protein 30S ribosomal subunit inhibitor
0,141  0,059  Carcinogenic, group 3
0,223  0,144  Angiogenesis inhibitor
0,119  0,041  GST T1-1 substrate
0,121  0,045  Antiprotozoal (Toxoplasma)
0,106  0,032  Antileprosy
0,111  0,036  Antiviral (Rhinovirus)
0,175  0,102  Platelet aggregation inhibitor
0,100  0,028  Histone deacetylase SIRT1 stimulant
0,100  0,028  Histone deacetylase stimulant
0,096  0,023  Glycine receptor agonist
0,101  0,030  Glutamate dehydrogenase inhibitor
0,129  0,058  Beta amyloid protein antagonist
0,076  0,008  Equilibrative nucleoside transport protein inhibitor
0,088  0,021  Protein kinase C eta inhibitor
0,095  0,028  Narcotic antagonist
0,076  0,009  Thymidine kinase inhibitor
0,126  0,059  Cholesterol synthesis inhibitor
0,086  0,022  Neuraminidase inhibitor
0,215  0,151  CTGF expression inhibitor
0,107  0,045  Alcohol dehydrogenase inhibitor
0,064  0,002  Vanilloid 2 agonist
0,122  0,060  Antifungal (Pneumocystis)
0,234  0,175  Antineoplastic (non-Hodgkin's lymphoma)
0,081  0,022  Antiviral (Parainfluenza)
0,083  0,024  Argininosuccinate synthase inhibitor
0,067  0,008  Arginase inhibitor
0,064  0,008  Guanylate cyclase inhibitor
0,077  0,023  Andropause treatment
0,119  0,064  Protein-tyrosine phosphatase 1B inhibitor
0,084  0,029  Leukotriene antagonist
0,080  0,026  Antidote, heavy metal
0,104  0,050  Lanosterol 14 alpha demethylase inhibitor
0,151  0,097  Myocardial ischemia treatment
0,074  0,021  Sphingosine kinase inhibitor
0,054  0,003  Toll-Like receptor 4 agonist
0,109  0,060  HDL-cholesterol increasing
0,193  0,144  Transcription factor STAT3 inhibitor
0,077  0,028  Prostaglandin EP2 antagonist
0,125  0,077  Toll-Like receptor antagonist
0,049  0,001  Telomerase stimulant
0,059  0,011  Phosphoglycerate kinase inhibitor
0,068  0,021  Leukotriene B4 antagonist
0,094  0,048  Interleukin 5 antagonist
0,068  0,023  Lipocortins synthesis agonist
0,137  0,093  UGT2B9 substrate
0,070  0,026  Ornithine carbamoyltransferase inhibitor
0,082  0,041  CDC25A inhibitor
0,058  0,017  Microtubule stabilization
0,135  0,095  Protein-tyrosine phosphatase inhibitor
0,096  0,057  Uric acid excretion stimulant
0,107  0,069  Cystathionine beta-synthase inhibitor
0,051  0,013  Fumarate hydratase inhibitor
0,060  0,023  Glucose-6-phosphate translocase inhibitor
0,104  0,069  DNA intercalator
0,134  0,100  Heat shock protein 70 antagonist
0,037  0,003  Antibiotic Anthracycline-like
0,039  0,005  GRP78 expression inhibitor
0,050  0,016  Sphingosine kinase 1 inhibitor
0,148  0,115  Succinate dehydrogenase inhibitor
0,058  0,025  Anesthetic inhalation
0,067  0,034  Biliverdin reductase inhibitor
0,043  0,012  Nucleoside transporters inhibitor
0,036  0,005  1,3-Beta-glucan synthase inhibitor
0,051  0,022  Neuraminidase (Influenza A) inhibitor
0,041  0,012  Hypoxanthine phosphoribosyltransferase inhibitor
0,110  0,081  Constipation treatment
0,068  0,040  CDC25B inhibitor
0,125  0,097  Corneal wound healing stimulator
0,083  0,055  Antiviral (RSV)
0,032  0,005  Isoleucine-tRNA ligase inhibitor
0,030  0,003  O6-alkylguanine-DNA alkyltransferase inhibitor
0,121  0,094  Antineoplastic (carcinoma)
0,063  0,036  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,036  0,010  Prostaglandin EP2 agonist
0,151  0,125  Osteoarthritis treatment
0,039  0,013  Prostaglandin D2 agonist
0,033  0,008  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,029  0,005  Ileal bile acid transport inhibitor
0,104  0,079  Acetylcholine release stimulant
0,034  0,010  Adenosine A1 receptor agonist
0,037  0,013  Protein kinase C beta I inhibitor
0,054  0,032  Vanilloid 2 antagonist
0,032  0,010  Thymidine phosphorylase inhibitor
0,086  0,066  Aminoacyl-tRNA synthetase inhibitor
0,083  0,064  Ornithine decarboxylase inhibitor
0,110  0,091  Anesthetic
0,038  0,019  Squalene synthetase inhibitor
0,069  0,050  Protein kinase C beta inhibitor
0,029  0,009  Prostaglandin F2 alpha agonist
0,122  0,103  SULT1A3 substrate
0,055  0,038  Sphingosine kinase 2 inhibitor
0,037  0,020  HMG CoA reductase inhibitor
0,050  0,035  Lysophosphatidic acid 3 receptor antagonist
0,067  0,052  Peroxisome proliferator-activated receptor gamma agonist
0,038  0,023  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,181  0,166  Transcription factor STAT inhibitor
0,064  0,050  Hypercalcemia treatment
0,085  0,070  Potassium channel (Ca-activated) activator
0,022  0,008  Prostacyclin agonist
0,138  0,125  Cardiodepressant
0,052  0,041  Ribonucleotide reductase inhibitor
0,063  0,053  Potassium channel large-conductance Ca-activated activator
0,018  0,008  Antibiotic Macrolide-like
0,018  0,009  Vitamin D receptor agonist
0,048  0,039  Factor III inhibitor
0,022  0,013  Inosine monophosphate dehydrogenase 1 inhibitor
0,065  0,057  Anticholelithogenic
0,022  0,014  Corticosteroid-like
0,083  0,074  Paget's disease treatment
0,223  0,216  Antineoplastic (myeloid leukemia)
0,105  0,098  Contraceptive female
0,030  0,023  Prostaglandin agonist
0,012  0,005  Purinergic P2Y2 agonist
0,031  0,025  Melatonin 2 agonist
0,048  0,041  Aldose reductase inhibitor
0,068  0,062  Adenosine A3 receptor antagonist
0,016  0,010  Purinergic P2Y1 agonist
0,108  0,103  Gastritis treatment
0,043  0,039  Peroxisome proliferator-activated receptor alpha agonist
0,016  0,012  Adenosine A2 receptor agonist
0,047  0,043  Ribonucleoside-diphosphate reductase inhibitor
0,013  0,010  Lysophosphatidic acid receptor 3 agonist
0,014  0,011  Purinergic receptor agonist
0,014  0,011  Purinergic P2 agonist
0,118  0,115  Anticoagulant
0,108  0,106  Antihelmintic (Trematoda)
0,152  0,150  Antineoplastic enhancer
0,047  0,045  Carbonic anhydrase IX inhibitor
0,032  0,031  Inosine monophosphate dehydrogenase inhibitor
0,017  0,016  Methylmalonyl-CoA mutase inhibitor
0,062  0,062  Lipase inhibitor

